Ligand Pharmaceuticals
LGND
LGND
326 hedge funds and large institutions have $4.09B invested in Ligand Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 60 funds opening new positions, 96 increasing their positions, 128 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
326
Holders Change
+28
Holders Change %
+9.4%
% of All Funds
7.48%
Holding in Top 10
12
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+71.43%
% of All Funds
0.28%
New
60
Increased
96
Reduced
128
Closed
26
Calls
$9.61M
Puts
$12.8M
Net Calls
-$3.15M
Net Calls Change
+$7.91M
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$60.3M |
| 2 |
Renaissance Technologies
New York
|
+$52M |
| 3 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$33.2M |
| 4 |
Two Sigma Investments
New York
|
+$24.7M |
| 5 |
Two Sigma Advisers
New York
|
+$22.8M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
351
ClearBridge Investments
New York
| – | -$2K | -22 | Closed |
|